Detalhe da pesquisa
1.
Impact of polyethylene glycol loxenatide on cardiovascular outcomes in patients with type 2 diabetes: study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (BALANCE-3).
BMJ Open
; 13(5): e069080, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37192802